BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 14519635)

  • 1. Expression of endothelin-1, endothelin-A, and endothelin-B receptor in human breast cancer and correlation with long-term follow-up.
    Wülfing P; Diallo R; Kersting C; Wülfing C; Poremba C; Rody A; Greb RR; Böcker W; Kiesel L
    Clin Cancer Res; 2003 Sep; 9(11):4125-31. PubMed ID: 14519635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the endothelin axis in bladder cancer: relationship to clinicopathologic parameters and long-term survival.
    Wülfing C; Eltze E; Yamini J; Wülfing P; Bierer S; Böcker W; Hertle L; Semjonow A; Sievert KD
    Eur Urol; 2005 May; 47(5):593-600. PubMed ID: 15826749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parameters.
    Eltze E; Wild PJ; Wülfing C; Zwarthoff EC; Burger M; Stoehr R; Korsching E; Hartmann A
    Eur Urol; 2009 Nov; 56(5):837-45. PubMed ID: 18945538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and prognostic relevance of endothelin-B receptor in vulvar cancer.
    Eltze E; Bertolin M; Korsching E; Wülfing P; Maggino T; Lellé R
    Oncol Rep; 2007 Aug; 18(2):305-11. PubMed ID: 17611649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of endothelin-1 and endothelin-A and endothelin-B receptors in high-grade prostatic intraepithelial neoplasia and prostate cancer.
    Montironi R; Mazzucchelli R; Barbisan F; Stramazzotti D; Santinelli A; Lòpez Beltran A; Cheng L; Montorsi F; Scarpelli M
    Eur Urol; 2007 Dec; 52(6):1682-9. PubMed ID: 17368711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of endothelin A receptor expression to prognosis of nasopharyngeal carcinoma].
    Mai HQ; Zeng ZY; Zhang HZ; Hou JH; Mo HY; Guo X; Min HQ; Hong MH
    Ai Zheng; 2005 May; 24(5):611-5. PubMed ID: 15890108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct patterns of endothelin axis expression in primary prostate cancer.
    Godara G; Pecher S; Jukic DM; D'Antonio JM; Akhavan A; Nelson JB; Pflug BR
    Urology; 2007 Jul; 70(1):209-15. PubMed ID: 17656249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-1, Endothelin-A- and Endothelin-B-receptor expression in preinvasive and invasive breast disease.
    Wülfing P; Diallo R; Kersting C; Wülfing C; Poremba C; Greb RR; Böcker W; Kiesel L
    Oncol Rep; 2004 Apr; 11(4):791-6. PubMed ID: 15010874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients.
    Korkolis DP; Tsoli E; Fouskakis D; Yiotis J; Koullias GJ; Giannopoulos D; Papalambros E; Nikiteas NI; Spiliopoulou CA; Patsouris E; Asimacopoulos P; Gorgoulis VG
    Anticancer Res; 2004; 24(3b):2061-8. PubMed ID: 15274401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term prognostic significance of HER-2/neu in untreated node-negative breast cancer depends on the method of testing.
    Schmidt M; Lewark B; Kohlschmidt N; Glawatz C; Steiner E; Tanner B; Pilch H; Weikel W; Kölbl H; Lehr HA
    Breast Cancer Res; 2005; 7(2):R256-66. PubMed ID: 15743506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
    Al Sarakbi W; Mokbel R; Salhab M; Jiang WG; Reed MJ; Mokbel K
    Anticancer Res; 2006; 26(6C):4985-90. PubMed ID: 17214375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.
    Holm NT; Byrnes K; Li BD; Turnage RH; Abreo F; Mathis JM; Chu QD
    J Surg Res; 2007 Jul; 141(1):53-9. PubMed ID: 17574038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
    Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S
    J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-1 stimulates human adipocyte lipolysis through the ET A receptor.
    Eriksson AK; van Harmelen V; Stenson BM; Aström G; Wåhlén K; Laurencikiene J; Rydén M
    Int J Obes (Lond); 2009 Jan; 33(1):67-74. PubMed ID: 18982011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of osteopontin in patients with triple-negative breast cancer.
    Wang X; Chao L; Ma G; Chen L; Tian B; Zang Y; Sun J
    Eur J Clin Invest; 2008 Jun; 38(6):438-46. PubMed ID: 18452545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the endothelin axis and microvessel density in bladder cancer - correlation with tumor angiogenesis and clinical prognosis.
    Herrmann E; Bögemann M; Bierer S; Eltze E; Toma MI; Köpke T; Hertle L; Wülfing C
    Oncol Rep; 2007 Jul; 18(1):133-8. PubMed ID: 17549358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis.
    Nakamura Y; Yasuoka H; Tsujimoto M; Yoshidome K; Nakahara M; Nakao K; Nakamura M; Kakudo K
    Clin Cancer Res; 2006 Feb; 12(4):1201-7. PubMed ID: 16489074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.